SOPHiA GENETICS Competitors and Similar CompaniesClear all

SOPHiA GENETICS's competitors and similar companies include Exscientia, Genomic Health, Veracyte, Guardant Health and CellCarta.
SOPHiA GENETICS
SOPHiA GENETICS
SOPHiA GENETICS is a healthcare technology company focused on establishing the practice of data-driven medicine.
Exscientia
Exscientia
Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery.
Genomic Health
Genomic Health
Genomic Health is a company that provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests.
Veracyte
Veracyte
Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.
Guardant Health
Guardant Health
Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.
CellCarta
CellCarta
CellCarta (formerly known as HistoGeneX) is a service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA, and BELAC-accredited laboratory.
Founding Date
Founding Date
2011
Founding Date
2012
Founding Date
2000
Founding Date
2008
Founding Date
2012
Founding Date
2001
Type
Type
Public
Type
Subsidiary
Type
Subsidiary
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Rolle, CH HQ
Bidart, FR
Boston, US
Locations
Oxford, GB HQ
Wien, AT
Osaka, JP
Dundee, GB
Miami, US
Locations
Redwood City, US HQ
Köln, DE
Chiyoda City, JP
London, GB
Locations
South San Francisco, US HQ
Marseille, FR
Haifa, IL
Austin, US
San Diego, US
Locations
Redwood City, US HQ
Locations
Antwerpen, BE HQ
Berchem, BE
Naperville, US
Employees
Employees
423
Employees
88
Employees
311
Employees
8154% increase
Employees
1,7681% decrease
Employees
4
Valuation ($)
Valuation ($)
236.4 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
2.6 b
Valuation ($)
2.7 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$65.2m (FY, 2024)
Revenue (est.)
£20.1m (FY, 2023)
Revenue (est.)
$394.1m (FY, 2018)
Revenue (est.)
$517.1m (FY, 2025)
Revenue (est.)
$982m (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$17.7m (FY, 2024)
Cost of goods
£10.5m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$349m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
$47.6m (FY, 2024)
Gross profit
£10.8m (FY, 2023)
Gross profit
N/A
Gross profit
$362.5m (FY, 2025)
Gross profit
$633m (FY, 2025)
Gross profit
N/A
Net income
Net income
($62.5m) (FY, 2024)
Net income
(£146m) (FY, 2023)
Net income
$25.7m (FY, 2018)
Net income
$66.4m (FY, 2025)
Net income
($416.3m) (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 245.8m
Total funding raised
$ 430.2m
Total funding raised
N/A
Total funding raised
$ 116.3m
Total funding raised
$ 550m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Exscientia
HQ
Oxford, GB

Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery.

View company
Genomic Health
HQ
Redwood City, US

Genomic Health is a company that provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests.

View company
Veracyte
HQ
South San Francisco, US
Employees
815↑ 4% increase

Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.

View company
Guardant Health
HQ
Redwood City, US
Employees
1,768↓ 1% decrease

Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.

View company